These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2420605)

  • 1. Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs.
    Dugas B; Vazquez A; Delfraissy JF; Gérard JP; Rannou MT; Galanaud P
    Eur J Immunol; 1986 Feb; 16(2):162-7. PubMed ID: 2420605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in human B cell activation: metabolic pathways vary according to the first signal used.
    Dugas B; Vazquez A; Klein B; Delfraissy JF; Rammou M; Gerard JP; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1609-14. PubMed ID: 3028818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL; Fauci AS
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation.
    Dugas B; Delfraissy JF; Calenda A; Peuchmaur M; Wallon C; Rannou MT; Galanaud P
    J Immunol; 1988 Dec; 141(12):4344-51. PubMed ID: 2848895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular but not intracellular calcium mobilization is required for Epstein-Barr virus-containing supernatant-induced B cell activation.
    Dugas B; Mencia-Huerta JM; Braquet P; Galanaud P; Delfraissy JF
    Eur J Immunol; 1989 Oct; 19(10):1867-71. PubMed ID: 2555195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT; Crawford DH
    Immunology; 1987 Oct; 62(2):279-84. PubMed ID: 2824347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation.
    Anastassiou ED; Yamada H; Francis ML; Mond JJ; Tsokos GC
    J Immunol; 1990 Oct; 145(8):2375-80. PubMed ID: 2120330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional properties of two human B cell growth factor species separated by lectin affinity column.
    Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
    J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
    Pezzutto A; Dörken B; Moldenhauer G; Clark EA
    J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.